Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia
Clinical trial NCT04463953 · COMPLETED
Trial details
- NCT number
- NCT04463953
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-12-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.